Replies to post #5 on Transdel Pharmaceuticals, Inc. (TDLP)

[Camaro1093]

In the Thomas Weisel conference, the CEO seemed very positive about Ketotransdel, IMO. If I remember correctly, the CEO said that the next illness they will develop a drug for with their topical Transdel technology is for Osteoarthritis.

JMO.

GLTA!